177-lutetium-PNT-2004

N/A

Report date: 2025/12/02 14:06:58
NME

Base Information

Drug Name177-lutetium-PNT-2004
Drug Alias Name177 lutetium PNT 2004177-Lu-PNT-2004PNT-2004-Lu-177-isotopePNT-2004-lutetium-177-isotopePNT-2004
ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug ConjugatesSmall molecules +[4] 
Mechanisms of ActionIonising radiation emittersFibroblast activation protein alpha antagonistsPositron-emission tomography enhancers +[4] 
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPoint Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTufts UniversityPoint Biopharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A